A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors

NCT06008054 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

376

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophageal Cancer
Gastric Cancer
Colorectal Cancer

Interventions

DRUG: SI-B003
DRUG: BL-B01D1
DRUG: PD-1 Monoclonal Antibody

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]